Nanoparticles having oligonucleotides attached thereto and uses therefor
View Patent ↗The invention provides methods of detecting a nucleic acid. The methods comprise contacting the nucleic acid with one or more types of particles having oligonucleotides attached thereto. In one embodiment of the method, the oligonucleotides are attached to nanoparticles and have sequences complementary to portions of the sequence of the nucleic acid. A detectable change (preferably a color change) is brought about as a result of the hybridization of the oligonucleotides on the nanoparticles to the nucleic acid. The invention also provides compositions and kits comprising particles. The invention further provides methods of synthesizing unique nanoparticle-oligonucleotide conjugates, the conjugates produced by the methods, and methods of using the conjugates. In addition, the invention provides nanomaterials and nanostructures comprising nanoparticles and methods of nanofabrication utilizing nanoparticles. Finally, the invention provides a method of separating a selected nucleic acid from other nucleic acids.
1. Nanoparticles having at least two types of oligonucleotides attached thereto, the oligonucleotides being present on a surface of the nanoparticles at a surface density of at least 10 picomoles/cm 2 , at least one type of oligonucleotides comprises recognition oligonucleotides, the recognition oligonucleotides comprising a spacer portion and a recognition portion, the recognition portion having a sequence complementary to at least one portion of the sequence of a nucleic acid or another oligonucleotide; and a second type of oligonucleotides comprises diluent oligonucleotides, wherein the spacer portion of the recognition oligonucleotides and diluent oligonucleotides have functional groups that are attached to the nanoparticles.
2. The nanoparticles of claim 1 wherein the oligonucleotides are present on the surface of the nanoparticles at a surface density of at least 15 picomoles/cm 2 .
3. The nanoparticles of claim 1 wherein the oligonucleotides are present on the surface of the nanoparticles at a surface density from about 15 picomoles/cm 2 to about 40 picomoles/cm 2 .
4. The nanoparticles of claim 1 wherein the nanoparticles are metal nanoparticles or semiconductor nanoparticles.
5. The nanoparticles of claim 4 wherein the nanoparticles are gold nanoparticles.
6. The nanoparticles of claim 1 wherein the spacer portion comprises at least about 10 nucleotides.
7. The nanoparticles of claim 6 wherein the spacer portion comprises from about 10 to about 30 nucleotides.
8. The nanoparticles of claim 1 wherein the bases of the nucleotides of the spacer portion are all adenines, all thymines, all cytosines, all uracils or all guanines.
9. The nanoparticles of claim 1 wherein the diluent oligonucleotides contain about the same number of nucleotides as are contained in the spacer portions of the recognition oligonucleotides.
10. The nanoparticles of claim 9 wherein the sequence of the diluent oligonucleotides is the same as that of the spacer portions of the recognition oligonucleotides.